Covered recipient · General Payments record
LANE NIRAMOLPHISAL DUDO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,213.36
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,235.27 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $577.15 | 16 |
| Janssen Scientific Affairs, LLC | $350.57 | 3 |
| Janssen Biotech, Inc. | $89.80 | 1 |
| GENZYME CORPORATION | $62.98 | 2 |
| QOL Medical, LLC | $38.45 | 2 |
| Gilead Sciences, Inc. | $25.42 | 1 |
| Ardelyx, Inc. | $23.80 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.70 | 1 |
| Phathom Pharmaceuticals, Inc. | $16.68 | 1 |
| EVOKE PHARMA, INC. | $16.26 | 1 |
| Ipsen Biopharmaceuticals, Inc | $14.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $115.42 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045230 | CMS |
| ABBVIE INC. | $17.75 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045232 | CMS |
| ABBVIE INC. | $15.07 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045234 | CMS |
| ABBVIE INC. | $15.74 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045236 | CMS |
| ABBVIE INC. | $15.17 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045238 | CMS |
| ABBVIE INC. | $18.11 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045240 | CMS |
| ABBVIE INC. | $74.69 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045242 | CMS |
| ABBVIE INC. | $17.58 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045244 | CMS |
| ABBVIE INC. | $9.53 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045246 | CMS |
| ABBVIE INC. | $8.24 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045248 | CMS |
| ABBVIE INC. | $17.00 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045250 | CMS |
| ABBVIE INC. | $13.57 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045252 | CMS |
| ABBVIE INC. | $8.13 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045254 | CMS |
| ABBVIE INC. | $109.59 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045256 | CMS |
| ABBVIE INC. | $12.44 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045258 | CMS |
| ABBVIE INC. | $109.12 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107045260 | CMS |
| Ardelyx, Inc. | $23.80 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146725040 | CMS |
| EVOKE PHARMA, INC. | $16.26 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127776027 | CMS |
| GENZYME CORPORATION | $21.57 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139808193 | CMS |
| GENZYME CORPORATION | $41.41 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139808229 | CMS |
| Gilead Sciences, Inc. | $25.42 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133654012 | CMS |
| Ipsen Biopharmaceuticals, Inc | $14.46 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091977987 | CMS |
| Janssen Biotech, Inc. | $89.80 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078773409 | CMS |
| Janssen Scientific Affairs, LLC | $111.26 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078860939 | CMS |
| Janssen Scientific Affairs, LLC | $102.26 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078860981 | CMS |
| Janssen Scientific Affairs, LLC | $137.05 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078860925 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.68 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151162068 | CMS |
| QOL Medical, LLC | $16.98 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147737133 | CMS |
| QOL Medical, LLC | $21.47 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147737135 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.70 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137736844 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.